Apyx Medical Corporation (APYX)
USD 1.16
(-5.69%)
USD 1.16
(-5.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.25 Million USD | 15.33% |
| 2022 | -23.56 Million USD | -63.08% |
| 2021 | -14.44 Million USD | 28.06% |
| 2020 | -20.08 Million USD | 3.96% |
| 2019 | -20.91 Million USD | -53.76% |
| 2018 | -13.6 Million USD | -158.31% |
| 2017 | -5.26 Million USD | -38.84% |
| 2016 | -3.79 Million USD | 45.72% |
| 2015 | -6.98 Million USD | -19.44% |
| 2014 | -5.84 Million USD | -59.55% |
| 2013 | -3.66 Million USD | -450.48% |
| 2012 | 1.04 Million USD | 5911.11% |
| 2011 | -18 Thousand USD | 99.35% |
| 2010 | -2.75 Million USD | -484.98% |
| 2009 | 714.84 Thousand USD | -44.64% |
| 2008 | 1.29 Million USD | -38.7% |
| 2007 | 2.1 Million USD | -19.72% |
| 2006 | 2.62 Million USD | 549.52% |
| 2005 | 403.96 Thousand USD | -68.4% |
| 2004 | 1.27 Million USD | 79.47% |
| 2003 | 712.39 Thousand USD | 250.33% |
| 2002 | -473.89 Thousand USD | -181.2% |
| 2001 | 583.58 Thousand USD | 10.13% |
| 2000 | 529.89 Thousand USD | 124.67% |
| 1999 | -2.14 Million USD | -133.44% |
| 1998 | -920.16 Thousand USD | -370.97% |
| 1997 | 339.57 Thousand USD | -29.31% |
| 1996 | 480.4 Thousand USD | 318.86% |
| 1995 | -219.5 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.54 Million USD | 16.15% |
| 2024 Q1 | -6.61 Million USD | -14.53% |
| 2023 FY | -19.95 Million USD | 15.33% |
| 2023 Q1 | -5.61 Million USD | 5.43% |
| 2023 Q4 | -5.77 Million USD | -24.56% |
| 2023 Q3 | -4.63 Million USD | -275.47% |
| 2023 Q2 | -1.23 Million USD | 77.99% |
| 2022 Q3 | -5.78 Million USD | 3.25% |
| 2022 FY | -23.56 Million USD | -63.08% |
| 2022 Q4 | -5.93 Million USD | -2.61% |
| 2022 Q2 | -5.97 Million USD | -1.79% |
| 2022 Q1 | -5.87 Million USD | -246.99% |
| 2021 Q4 | -1.69 Million USD | 57.36% |
| 2021 FY | -14.44 Million USD | 28.06% |
| 2021 Q1 | -4.74 Million USD | -131.13% |
| 2021 Q2 | -4.04 Million USD | 14.79% |
| 2021 Q3 | -3.96 Million USD | 1.86% |
| 2020 FY | -20.08 Million USD | 3.96% |
| 2020 Q3 | -4.37 Million USD | 29.12% |
| 2020 Q2 | -6.16 Million USD | 17.69% |
| 2020 Q1 | -7.49 Million USD | -25.68% |
| 2020 Q4 | -2.05 Million USD | 53.03% |
| 2019 Q1 | -5.2 Million USD | -1.01% |
| 2019 FY | -20.91 Million USD | -53.76% |
| 2019 Q4 | -5.96 Million USD | -26.91% |
| 2019 Q3 | -4.69 Million USD | -5.2% |
| 2019 Q2 | -4.46 Million USD | 14.18% |
| 2018 Q1 | -864 Thousand USD | 20.59% |
| 2018 Q3 | -2.79 Million USD | -947.19% |
| 2018 Q4 | -5.15 Million USD | -84.23% |
| 2018 FY | -13.6 Million USD | -158.31% |
| 2018 Q2 | -267 Thousand USD | 69.1% |
| 2017 Q3 | -1.13 Million USD | 13.17% |
| 2017 FY | -5.26 Million USD | -38.84% |
| 2017 Q2 | -1.3 Million USD | 24.81% |
| 2017 Q1 | -1.73 Million USD | -66.38% |
| 2017 Q4 | -1.08 Million USD | 4.06% |
| 2016 Q4 | -1.04 Million USD | -326.12% |
| 2016 Q3 | -245 Thousand USD | 51.96% |
| 2016 Q2 | -510 Thousand USD | 74.41% |
| 2016 Q1 | -1.99 Million USD | -47.19% |
| 2016 FY | -3.79 Million USD | 45.72% |
| 2015 FY | -6.98 Million USD | -19.44% |
| 2015 Q4 | -1.35 Million USD | 25.32% |
| 2015 Q3 | -1.81 Million USD | -17.12% |
| 2015 Q2 | -1.54 Million USD | 31.87% |
| 2015 Q1 | -2.27 Million USD | -26.79% |
| 2014 Q2 | -1.74 Million USD | -3110.34% |
| 2014 Q1 | 58 Thousand USD | 106.62% |
| 2014 Q3 | -2.36 Million USD | -35.57% |
| 2014 FY | -5.84 Million USD | -59.55% |
| 2014 Q4 | -1.79 Million USD | 24.29% |
| 2013 Q3 | -475 Thousand USD | 71.21% |
| 2013 FY | -3.66 Million USD | -450.48% |
| 2013 Q4 | -876 Thousand USD | -84.42% |
| 2013 Q2 | -1.65 Million USD | -148.12% |
| 2013 Q1 | -665 Thousand USD | -619.53% |
| 2012 Q2 | 240 Thousand USD | -39.39% |
| 2012 Q3 | 282 Thousand USD | 17.5% |
| 2012 FY | 1.04 Million USD | 5911.11% |
| 2012 Q4 | 128 Thousand USD | -54.61% |
| 2012 Q1 | 396 Thousand USD | 128.27% |
| 2011 Q4 | -1.4 Million USD | -664.92% |
| 2011 Q3 | 248 Thousand USD | -54.83% |
| 2011 Q1 | 585 Thousand USD | 138.65% |
| 2011 Q2 | 549 Thousand USD | -6.15% |
| 2011 FY | -18 Thousand USD | 99.35% |
| 2010 FY | -2.75 Million USD | -484.98% |
| 2010 Q3 | -115.1 Thousand USD | 85.45% |
| 2010 Q4 | -1.51 Million USD | -1214.76% |
| 2010 Q2 | -791.3 Thousand USD | -138.22% |
| 2010 Q1 | -332.18 Thousand USD | -3141.38% |
| 2009 Q1 | 542.65 Thousand USD | 278.63% |
| 2009 Q4 | 10.92 Thousand USD | 109.88% |
| 2009 Q3 | -110.49 Thousand USD | -140.06% |
| 2009 Q2 | 275.81 Thousand USD | -49.17% |
| 2009 FY | 714.84 Thousand USD | -44.64% |
| 2008 Q4 | 143.32 Thousand USD | -76.61% |
| 2008 Q2 | 245.44 Thousand USD | -15.06% |
| 2008 Q1 | 288.94 Thousand USD | -31.07% |
| 2008 FY | 1.29 Million USD | -38.7% |
| 2008 Q3 | 612.68 Thousand USD | 149.62% |
| 2007 Q1 | 390.61 Thousand USD | -1.65% |
| 2007 Q2 | 580.66 Thousand USD | 48.65% |
| 2007 Q4 | 419.2 Thousand USD | -41.03% |
| 2007 Q3 | 710.83 Thousand USD | 22.42% |
| 2007 FY | 2.1 Million USD | -19.72% |
| 2006 Q2 | 711.5 Thousand USD | 2.43% |
| 2006 Q3 | 830.65 Thousand USD | 16.75% |
| 2006 Q4 | 397.17 Thousand USD | -52.19% |
| 2006 FY | 2.62 Million USD | 549.52% |
| 2006 Q1 | 694.64 Thousand USD | 156.36% |
| 2005 FY | 403.96 Thousand USD | -68.4% |
| 2005 Q3 | 168.52 Thousand USD | 234.44% |
| 2005 Q4 | 270.96 Thousand USD | 60.78% |
| 2005 Q1 | 82.33 Thousand USD | -17.81% |
| 2005 Q2 | -125.35 Thousand USD | -252.25% |
| 2004 FY | 1.27 Million USD | 79.47% |
| 2004 Q1 | 243.72 Thousand USD | 194.03% |
| 2004 Q2 | 407.98 Thousand USD | 67.4% |
| 2004 Q3 | 526.66 Thousand USD | 29.09% |
| 2004 Q4 | 100.18 Thousand USD | -80.98% |
| 2003 FY | 712.39 Thousand USD | 250.33% |
| 2003 Q2 | 475.36 Thousand USD | 599.04% |
| 2003 Q1 | 68 Thousand USD | 120.38% |
| 2003 Q4 | -259.19 Thousand USD | -160.53% |
| 2003 Q3 | 428.23 Thousand USD | -9.91% |
| 2002 Q2 | -44.63 Thousand USD | -3.84% |
| 2002 FY | -473.89 Thousand USD | -181.2% |
| 2002 Q4 | -333.67 Thousand USD | -534.41% |
| 2002 Q3 | -52.59 Thousand USD | -17.83% |
| 2002 Q1 | -42.98 Thousand USD | -215.11% |
| 2001 Q2 | 117.62 Thousand USD | 25.65% |
| 2001 Q4 | 37.34 Thousand USD | -88.85% |
| 2001 Q3 | 334.99 Thousand USD | 184.8% |
| 2001 Q1 | 93.61 Thousand USD | 74.27% |
| 2001 FY | 583.58 Thousand USD | 10.13% |
| 2000 Q1 | 56.98 Thousand USD | 0.0% |
| 2000 Q2 | 258.88 Thousand USD | 354.31% |
| 2000 Q3 | 160.3 Thousand USD | -38.08% |
| 2000 FY | 529.89 Thousand USD | 124.67% |
| 2000 Q4 | 53.71 Thousand USD | -66.49% |
| 1999 FY | -2.14 Million USD | -133.44% |
| 1998 FY | -920.16 Thousand USD | -370.97% |
| 1997 FY | 339.57 Thousand USD | -29.31% |
| 1996 FY | 480.4 Thousand USD | 318.86% |
| 1995 FY | -219.5 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -20.18% |
| Cerus Corporation | -30.05 Million USD | 42.571% |
| OrthoPediatrics Corp. | -25.76 Million USD | 33.016% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -62.494% |
| Talis Biomedical Corporation | -66.81 Million USD | 74.169% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 0.214% |
| Inogen, Inc. | -109.38 Million USD | 84.222% |
| Spectral AI, Inc. | -12.98 Million USD | -32.925% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 72.425% |
| CVRx, Inc. | -43.1 Million USD | 59.959% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -389.201% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -38.872% |
| Orthofix Medical Inc. | -139.11 Million USD | 87.593% |
| Venus Concept Inc. | -28.3 Million USD | 39.034% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 68.055% |
| Bioventus Inc. | -81.72 Million USD | 78.882% |
| BrainsWay Ltd. | -4.92 Million USD | -250.294% |
| Envoy Medical, Inc. | -18.37 Million USD | 6.053% |
| electroCore, Inc. | -18.8 Million USD | 8.221% |
| IceCure Medical Ltd | -15.57 Million USD | -10.805% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 64.401% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 0.052% |
| MaxCyte, Inc. | -48.29 Million USD | 64.266% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -44.363% |
| Nexalin Technology, Inc. | -5.69 Million USD | -202.986% |
| PAVmed Inc | -68.79 Million USD | 74.912% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 69.487% |
| RxSight, Inc. | -50.08 Million USD | 65.541% |
| Sight Sciences, Inc. | -57.27 Million USD | 69.866% |
| SI-BONE, Inc. | -46.93 Million USD | 63.225% |
| TELA Bio, Inc. | -44.07 Million USD | 60.842% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 68.127% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 66.44% |
| LivaNova PLC | -68.49 Million USD | 74.804% |
| 908 Devices Inc. | -42.75 Million USD | 59.636% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 90.046% |
| Nemaura Medical Inc. | -9.59 Million USD | -79.871% |
| NeuroPace, Inc. | -27.17 Million USD | 36.487% |
| LENSAR, Inc. | -12.22 Million USD | -41.132% |
| Cutera, Inc. | -156.23 Million USD | 88.953% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -100.593% |
| BioSig Technologies, Inc. | -28.51 Million USD | 39.468% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 80.307% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 23.109% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 115.475% |
| Axonics, Inc. | -26.05 Million USD | 33.764% |
| Outset Medical, Inc. | -169.77 Million USD | 89.834% |
| IRIDEX Corporation | -10 Million USD | -72.469% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 84.191% |
| IRadimed Corporation | 20.03 Million USD | 186.142% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -109.327% |
| INVO Bioscience, Inc. | -6.76 Million USD | -155.041% |
| Telesis Bio, Inc. | -35.15 Million USD | 50.899% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 220.44% |
| Varex Imaging Corporation | 32.1 Million USD | 153.766% |
| Quipt Home Medical Corp. | 3.91 Million USD | 540.393% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -42.248% |
| Pulmonx Corporation | -61.93 Million USD | 72.134% |
| Dynatronics Corporation | -2.27 Million USD | -659.289% |
| Modular Medical, Inc. | -17.52 Million USD | 1.54% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -17.897% |
| Semler Scientific, Inc. | 22.25 Million USD | 177.548% |
| InMode Ltd. | 195.66 Million USD | 108.821% |
| Bruker Corporation | 436.9 Million USD | 103.95% |
| Cytosorbents Corporation | -31.2 Million USD | 44.699% |
| DexCom, Inc. | 597.7 Million USD | 102.888% |
| Align Technology, Inc. | 643.33 Million USD | 102.683% |
| Viveve Medical, Inc. | -21.55 Million USD | 19.923% |
| ZimVie Inc. | -30.93 Million USD | 44.216% |
| Movano Inc. | -29.69 Million USD | 41.869% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 38.018% |
| Nexalin Technology, Inc. | -5.69 Million USD | -202.986% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -389.201% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 92.6% |
| Profound Medical Corp. | -28.61 Million USD | 39.688% |
| Insulet Corporation | 220 Million USD | 107.845% |
| enVVeno Medical Corporation | -25.23 Million USD | 31.615% |
| Surmodics, Inc. | -5.64 Million USD | -205.74% |
| iCAD, Inc. | -7.68 Million USD | -124.464% |
| Nuwellis, Inc. | -17.63 Million USD | 2.104% |
| Biotricity, Inc. | -8.82 Million USD | -95.497% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 86.211% |
| Aethlon Medical, Inc. | -12.63 Million USD | -36.58% |
| InspireMD, Inc. | -21.14 Million USD | 18.37% |
| PAVmed Inc. | -68.79 Million USD | 74.912% |
| BIOLASE, Inc. | -17.93 Million USD | 3.78% |
| Beyond Air, Inc. | -63 Million USD | 72.607% |
| FONAR Corporation | 16.53 Million USD | 204.376% |
| AxoGen, Inc. | -21.46 Million USD | 19.583% |
| Vivani Medical, Inc. | -26.96 Million USD | 35.995% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 195.665% |
| Inari Medical, Inc. | -14.03 Million USD | -22.997% |
| UFP Technologies, Inc. | 57.66 Million USD | 129.93% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -250.252% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -173.702% |
| Tenon Medical, Inc. | -15.72 Million USD | -9.741% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -130.921% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 59.587% |
| AdaptHealth Corp. | -598.4 Million USD | 97.116% |
| Sintx Technologies, Inc. | -13.35 Million USD | -29.203% |
| NanoVibronix, Inc. | -3.43 Million USD | -402.299% |
| Quanterix Corporation | -49.7 Million USD | 65.274% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -42.248% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -4418.063% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 94.84% |
| TransMedics Group, Inc. | -28.72 Million USD | 39.921% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 26.906% |
| NeuroMetrix, Inc. | -7.15 Million USD | -141.333% |
| Hyperfine, Inc. | -48.11 Million USD | 64.13% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 73.458% |
| Biomerica, Inc. | -6.36 Million USD | -171.07% |
| Bone Biologics Corporation | -9.42 Million USD | -83.055% |
| AVITA Medical, Inc. | -40.4 Million USD | 57.282% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -67.381% |
| Silk Road Medical, Inc | -59.27 Million USD | 70.881% |